[en] Genetically modified mice are indispensable for establishing the roles of platelets in arterial thrombosis and hemostasis. Microfluidics assays using anticoagulated whole blood are commonly used as integrative proxy tests for platelet function in mice. In the present study, we quantified the changes in collagen-dependent thrombus formation for 38 different strains of (genetically) modified mice, all measured with the same microfluidics chamber. The mice included were deficient in platelet receptors, protein kinases or phosphatases, small GTPases or other signaling or scaffold proteins. By standardized re-analysis of high-resolution microscopic images, detailed information was obtained on altered platelet adhesion, aggregation and/or activation. For a subset of 11 mouse strains, these platelet functions were further evaluated in rhodocytin- and laminin-dependent thrombus formation, thus allowing a comparison of glycoprotein VI (GPVI), C-type lectin-like receptor 2 (CLEC2) and integrin alpha6beta1 pathways. High homogeneity was found between wild-type mice datasets concerning adhesion and aggregation parameters. Quantitative comparison for the 38 modified mouse strains resulted in a matrix visualizing the impact of the respective (genetic) deficiency on thrombus formation with detailed insight into the type and extent of altered thrombus signatures. Network analysis revealed strong clusters of genes involved in GPVI signaling and Ca(2+) homeostasis. The majority of mice demonstrating an antithrombotic phenotype in vivo displayed with a larger or smaller reduction in multi-parameter analysis of collagen-dependent thrombus formation in vitro. Remarkably, in only approximately half of the mouse strains that displayed reduced arterial thrombosis in vivo, this was accompanied by impaired hemostasis. This was also reflected by comparing in vitro thrombus formation (by microfluidics) with alterations in in vivo bleeding time. In conclusion, the presently developed multi-parameter analysis of thrombus formation using microfluidics can be used to: (i) determine the severity of platelet abnormalities; (ii) distinguish between altered platelet adhesion, aggregation and activation; and (iii) elucidate both collagen and non-collagen dependent alterations of thrombus formation. This approach may thereby aid in the better understanding and better assessment of genetic variation that affect in vivo arterial thrombosis and hemostasis.
Stegner D, Nieswandt B. Platelet receptor signaling in thrombus formation. J Mol Med. (2011) 89:109–21. 10.1007/s00109-010-0691-521058007
Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. (2013) 93:327–58. 10.1152/physrev.00016.201123303912
Van der Meijden PE, Heemskerk JW. Platelet biology and functions: new concepts and future clinical perspectives Nat. Rev Cardiol. (2019) 16:166–79. 10.1182/blood-2008-07-171066
Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, et al. Glycoprotein VI but not α2β1 integrin is essential for platelet interaction with collagen. EMBO J. (2001) 20:2120–30. 10.1093/emboj/20.9.2120
Siljander PR, Munnix IC, Smethurst PA, Deckmyn H, Lindhout T, Ouwehand WH, et al. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood. (2004) 103:1333–41. 10.1182/blood-2003-03-088914563646
Auger JM, Kuijpers MJ, Senis YA, Watson SP, Heemskerk JW. Adhesion of human and mouse platelets to collagen under shear: a unifying model. FASEB J. (2005) 19:825–7. 10.1096/fj.04-1940fje15758040
Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol. (2008) 28:403–12. 10.1161/ATVBAHA.107.15047418174460
Senis YA, Mazharian A, Mori J. Src family kinases: at the forefront of platelet activation. Blood. (2014) 124:2013–24. 10.1182/blood-2014-01-45313425115887
Mammadova-Bach E, Nagy M, Heemskerk JW, Nieswandt N, Braun A. Store-operated calcium entry in blood cells in thrombo-inflammation. Cell Calcium. (2019) 77:39–48. 10.1016/j.ceca.2018.11.005
Harper MT, Poole AW. Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost. (2010) 8:454–62. 10.1111/j.1538-7836.2009.03722.x20002545
Guidetti GF, Canobbio I, Torti M. PI3K/Akt in platelet integrin signaling and implications in thrombosis. Adv Biol Regul. (2015) 59:36–52. 10.1016/j.jbior.2015.06.00126159296
Pleines I, Hagedorn I, Gupta S, May F, Chakarova L, van Hengel J, et al. Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis. Blood. (2012) 119:1054–63. 10.1182/blood-2011-08-37219322045984
Elvers M, Stegner D, Hagedorn I, Kleinschnitz C, Braun A, Kuijpers ME, et al. Impaired αIIbβ3 integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci. Signal. (2010) 3:ra1. 10.1126/scisignal.2000551
Coxon CH, Geer MJ, Senis YA. ITIM receptors: more than just inhibitors of platelet activation. Blood. (2017) 129:3407–18. 10.1182/blood-2016-12-72018528465343
Kunzelmann K, Nilius B, Owsianik G, Schreiber R, Ousingsawat J, Sirianant L, et al. Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel, or phospholipid scramblase? Pflugers Arch. (2014) 466:407–14. 10.1007/s00424-013-1305-1
De Witt SM, Verdoold R, Cosemans JM, Heemskerk JW. Insights into platelet-based control of coagulation. Thromb Res. (2014) 133:S139–S148. 10.1016/s0049-384850024-224862135
Mattheij NJ, Braun A, van Kruchten R, Castoldi E, Pircher J, Baaten CC, et al. Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage. FASEB J. (2016) 30:727–37. 10.1096/fj.15-28044626481309
Agbani EO, Poole AW. Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis. Blood. (2017) 130:2171–9. 10.1182/blood-2017-05-78725928972013
May F, Hagedorn I, Pleines I, Bender M, Vögtle T, Eble J, et al. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood. (2009) 114:3464–72. 10.1182/blood-2009-05-22227319641185
Watson SP, Herbert JM, Pollitt AY. GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost. (2010) 8:1457–67. 10.1111/j.1538-7836.2010.03875.x20345705
Schaff M, Tang C, Maurer E, Bourdon C, Receveur N, Eckly A, et al. Integrin α6β1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation, and arterial thrombosis. Circulation. (2013) 128:541–52. 10.1161/circulationaha.112.00079923797810
Baaten CC, Meacham S, de Witt SM, Feijge MA, Adams DJ, Akkerman JW, et al. A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding. Blood. (2018) 132:e35–46. 10.1182/blood-2018-02-83198230275110
De Witt SM, Swieringa F, Cavill R, Lamers MM, van Kruchten R, Mastenbroek T, et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun. (2014) 5:4257. 10.1038/ncomms525725027852
Brouns S, van Geffen JP, Heemskerk JW. High throughput measurement of platelet aggregation under flow. Platelets. (2018) 29:662–9. 10.1080/09537104.2018.144766029537929
Van Geffen JP, Brouns S, Batista J, McKinney H, Kempster CK, Sivapalaratnam S, et al. High-throughput elucidation of thrombus formation reveals sources of platelet function variability. Haematologica. (2019) 104:1256–67. 10.3324/haematol.2018.19885330545925
Kuchay SM, Kim N, Grunz EA, Fay WP, Chishti AH. Double knockouts reveal that protein tyrosine phosphatase 1β is a physiological target of calpain-1 in platelets. Mol Cell Biol. (2007) 27:6038–52. 10.1128/MCB.00522-07
Mattheij NJ, Gilio K, van Kruchten R, Jobe SM, Wieschhaus AJ, Chishti AH, et al. Dual mechanism of integrin αIIbβ3 closure in procoagulant platelets. J Biol Chem. (2013) 288:13325–11336. 10.1074/jbc.M112.42835923519467
Kuijpers MJ, de Witt S, Nergiz-Unal R, van Kruchten R, Korporaal SJ, Verhamme P, et al. Supporting roles of platelet thrombospondin-1 and CD36 in thrombus formation on collagen. Arterioscler Thromb Vasc Biol. (2014) 34:1187–92. 10.1161/atvbaha.113.30291724675658
Podrez EA, Byzova TV, Febbraio M, Salomon RG, Ma Y, Valiyaveettil M, et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med. (2007) 13:1086–95. 10.1038/nm162617721545
Pleines I, Eckly A, Elvers M, Hagedorn I, Eliautou S, Bender M, et al. Multiple alterations of platelet functions dominated by increased secretion in mice lacking Cdc42 in platelets. Blood. (2010) 115:3364–73. 10.1182/blood-2009-09-24227120139097
Mori J, Nagy Z, Di Nunzio G, Smith CW, Geer MJ, Al Ghaithi R, et al. Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148. Blood. (2018) 131:1122–44. 10.1182/blood-2017-02-76807729301754
Musumeci L, Kuijpers MJ, Gilio K, Hego A, Theatre E, Maurissen L, et al. Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis. Circulation. (2015) 131:656–68. 10.1161/circulationaha.114.01018625520375
Kuijpers MJ, Schulte V, Bergmeier W, Lindhout T, Brakebusch C, Offermanns S, et al. Complementary roles of glycoprotein VI and α2β1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo. Faseb J. (2003) 17:685–7. 10.1096/fj.02-0381fje12586747
Munnix IC, Strehl A, Kuijpers MJ, Auger JM, van der Meijden PE, van Zandvoort MA, et al. The glycoprotein VI-phospholipase Cγ2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro and in vivo. Arterioscler Thromb Vasc Biol. (2005) 25:2673–8. 10.1161/01.ATV.0000193568.71980.4a16254207
Offermanns S, Toombs CF, Hu YH, Simon MI. Defective platelet-activation in Gaq-deficient mice. Nature. (1997) 389:183–6. 10.1038/38284
Nieswandt B, Schulte V, Bergmeier W, Mokhtari-Nejad R, Rackebrandt K, Cazenave JP, et al. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med. (2001) 193:459–69. 10.1084/jem.193.4.45911181698
Bender M, May F, Lorenz V, Thielmann I, Hagedorn I, Finney BA, et al. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice. Arterioscler Thromb Vasc Biol. (2013) 33:926–34. 10.1161/ATVBAHA.112.30067223448972
Kuijpers MJ, Pozgajova M, Cosemans JM, Munnix IC, Eckes B, Nieswandt B, et al. Role of murine integrin α2β1 in thrombus stabilization and embolization: contribution of thromboxane A2. Thromb Haemost. (2007) 98:1072–80. 10.1160/TH07–02–008918000613
Grüner S, Prostredna M, Schulte V, Krieg T, Eckes B, Brakebusch C, et al. Multipe integrin-ligand interaction synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood. (2003) 102:4021–7. 10.1182/blood-2003-05-1391
Hofmann I, Geer MJ, Vögtle T, Crispin A, Campagna DR, Barr A, et al. Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice. Blood. (2018) 132:1399–412. 10.1182/blood-2017-08-80276929898956
Gilio K, van Kruchten R, Braun A, Berna-Erro A, Feijge MA, Stegner D, et al. Roles of platelet STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem. (2010) 285:23629–38. 10.1074/jbc.M110.10869620519511
Braun A, Varga-Szabo D, Kleinschnitz C, Pleines I, Bernder M, Austinat M, et al. Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood. (2009) 113:2056–63. 10.1182/blood-2008-07-17161118832659
Cosemans JM, Munnix IC, Wetzker R, Heller R, Jackson SP, Heemskerk JW. Continuous signaling via PI3K isoforms beta and gamma is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood. (2006) 108:3045–52. 10.1182/blood-2006-03-00633816840732
Hirsch E, Bosco O, Tropel P, Laffargue M, Calvez R, Altruda F, et al. Resistance to thromboembolism in PI3Kγ-deficient mice. FASEB J. (2001) 15:2019–21. 10.1096/fj.00-0810fje11511514
Elvers M, Pozgai R, Varga-Szabo D, May F, Pleines I, Kuijpers MJ, et al. Platelet hyperactivity and a prothrombotic phenotype in mice with a gain-of-function mutation in phospholipase Cγ2. J Thromb Haemost. (2010) 8:1353–63. 10.1111/j.1538-7836.2010.03838.x
Gilio K, Harper MT, Cosemans JM, Konopatskaya O, Munnix IC, Prinzen L, et al. Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen. J Biol Chem. (2010) 285:23410–9. 10.1074/jbc.M110.13617620479008
Konopatskaya O, Gilio K, Harper MT, Zhao Y, Cosemans JM, Karim AZ, et al. PKCα regulates platelet granule secretion and thrombus formation in mice. J Clin Invest. (2009) 119:399–407. 10.1172/JCI3466519147982
Chari R, Getz T, Nagy BJr, Bhavaraju K, Mao Y, Bynagari YS, et al. Protein kinase Cδ differentially regulates platelet functional responses. Arterioscler Thromb Vasc Biol. (2009) 29:699–705. 10.1161/atvbaha.109.184010
Konopatskaya O, Matthews SA, Harper MT, Gilio K, Cosemans JM, Williams CM, et al. Protein kinase C mediates platelet secretion and thrombus formation through protein kinase δ2. Blood. (2011) 118:416–24. 10.1182/blood-2010-10-312199
Pleines I, Elvers M, Strehl A, Pozgajova M, Varga-Szabo D, May F, et al. Rac1 is essential for phospholipase C-γ2 activation in platelets. Pflugers Arch. (2009) 457:1173–85. 10.1007/s00424-008-0573-718704487
Varga-Szabo D, Braun A, Kleinschnitz C, Bender M, Pleines I, Pham M, et al. The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J Exp Med. (2008) 205:1583–91. 10.1084/jem.2008030218559454
Hughes CE, Finney BA, Koentgen F, Lowe KL, Watson SP. The N-terminal SH2 domain of Syk is required for (hem)ITAM, but not integrin, signaling in mouse platelets. Blood. (2015) 125:144–54. 10.1182/blood-2014-05-579375
Suzuki-Inoue K, Kato Y, Kaneko MK, Mishima K, Yatomi Y, Yamazaki Y, et al. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem. (2007) 282:25993–6001. 10.1074/jbc.M70232720017616532
Hooley E, Papagrigoriou E, Navdaev A, Pandey AV, Clemetson JM, Clemetson KJ, et al. The crystal structure of the platelet activator aggretin reveals a novel (alphabeta)2 dimeric structure. Biochemistry. (2008) 47:7831–7. 10.1021/bi800528t18597489
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. (2012) 9:676–82. 10.1038/nmeth.201922743772
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acid Res. (2015) 43:D447–D452. 10.1093/nar/gku100325352553
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction network. Genome Res. (2003) 13:2498–504. 10.1101/gr.1239303
Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformat. (2003) 4:2. 10.1186/1471-2105-4-212525261
Miryala SK, Anbarasu A, Ramaiah S. Discerning molecular interactions: a comprehensive review on biomolecular interaction databases and network analysis tools. Gene. (2018) 642:84–94. 10.1016/j.gene.2017.11.02829129810
Team RC. R: A Language and Environment for Statistical Computing. Vienna: Foundation for statistical computing. Available online at: https://www.R-project.org (accessed 2019 2018)
Petersen R, Lambourne JJ, Javierre BM, Grassi L, Kreuzhuber R, Ruklisa D, et al. Platelet function is modified by common sequence variation in megakaryocyte super enhancers. Nat Commun. (2017) 8:16058. 10.1038/ncomms1605828703137
Von Hundelshausen P, Agten SM, Eckardt V, Blanchet X, Schmitt MM, Ippel H, et al. Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation. Sci. Transl. Med. (2017) 9:eaah6650. 10.1126/scitranslmed.aah665028381538
Suzuki-Inoue K, Inoue O, Ozaki Y. Novel platelet activation receptor CLEC-2: from discovery to prospects. J. Thromb. Haemost. (2011) 9:44–55. 10.1111/j.1538-7836.2011.04335.x21781241
Matus V, Valenzuela G, Sáez CG, Hidalgo P, Lagos M, Aranda E, et al. An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in four Chilean families. J Thromb Haemost. (2013) 11:1751–9. 10.1111/jth.1233423815599
Dumont B, Lasne D, Rothschild C, Bouabdelli M, Ollivier V, Oudin C, et al. Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood. (2009) 114:1900–3. 10.1182/blood-2009-03-21350419549989
Nagy M, Mastenbroek TG, Mattheij NJ, De Witt S, Clemetson KJ, Kirschner J, et al. Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies. Haematologica. (2018) 103:540–9. 10.3324/haematol.2017.17697429242293
